The global biopsy devices market, which was valued at USD 2.25 billion in 2023, is projected to expand significantly, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2030. Several key factors are contributing to the market's growth, including the rising global prevalence of cancer, an increasing emphasis on minimally invasive surgeries, the presence of untapped...